Submitted by elizabethwu1 on Thu, 10/03/2013 - 10:54am NCT01900665 Solanezumab United States Monday, July 1, 2013 – Wednesday, February 1, 2017 2 129 Phase 3 Alzheimer's Disease Friday, February 3, 2017 Eli Lilly & Co. Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by elizabethwu1 on
Submitted by elizabethwu1 on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.